ArticleESC heart failure2018

Empagliflozin reduces Ca/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes.

Julian Mustroph et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.